| Mrs Kendra Sam Williams, PHARM D | |
|
1556 Lapalco Blvd, Harvey, LA 70058-3304 | |
| (504) 367-9461 | |
| Not Available |
| Full Name | Mrs Kendra Sam Williams |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1556 Lapalco Blvd, Harvey, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548575640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17019 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kendra Sam Williams, PHARM D 1556 Lapalco Blvd, Harvey, LA 70058-3304 Ph: (504) 367-9461 | Mrs Kendra Sam Williams, PHARM D 1556 Lapalco Blvd, Harvey, LA 70058-3304 Ph: (504) 367-9461 |
News Archive
ThermoGenesis Corp.,a leading supplier of innovative products and services that process and store adult stem cells, said it has filed a Certificate of Amendment to its Amended and Restated Certification of Incorporation to effect its previously announced one-for-four reverse stock split of its common stock.
At the time when Dr. Roberto Bolli received word that he was awarded a $12.8 million grant renewal from the National Institutes of Health for one research project, five patients in another of his clinical trials at the University of Louisville have reached the successful endpoint of their participation.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
In a recently published article, researchers from Novozymes Biopharma (Nottingham, UK) and Malvern Panalytical (Malvern Panalytical, UK) describe collaborative work using light scattering techniques to demonstrate the short- and long-term stability of the novel recombinant human albumins Albucult® and Recombumin®.
rEVO Biologics Inc., a subsidiary of LFB SA, today announced the initiation of the Phase 3 clinical program for ATryn for the treatment of preeclampsia in pregnant women during the 24th to 28th week of pregnancy.
› Verified 2 days ago
Amanda Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lapalco Blvd, Harvey, LA 70058 Phone: 504-227-9830 | |
Destiney Robinson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Tunica Ct, Harvey, LA 70058 Phone: 504-908-1123 | |
Cheryl Kates-pendleton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1556 Lapalco Blvd, Harvey, LA 70058 Phone: 504-367-9461 Fax: 504-367-0965 | |
Jimmy Phan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1731 Manhattan Blvd, Harvey, LA 70058 Phone: 504-364-1659 | |
Kimberly Curington, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3153 Touchwood Dr, Harvey, LA 70058 Phone: 504-914-2455 | |
Paul Johnson Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4057 S Windmere St, Harvey, LA 70058 Phone: 504-689-4122 Fax: 504-689-4125 | |
Ishfaq Ahmad, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lapalco Blvd, Harvey, LA 70058 Phone: 504-227-9830 Fax: 504-227-9836 |